185 related articles for article (PubMed ID: 31050379)
1. External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy.
Lee HW; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Kim BK
Liver Int; 2019 Sep; 39(9):1624-1630. PubMed ID: 31050379
[TBL] [Abstract][Full Text] [Related]
2. Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy.
Kim JH; Kim YD; Lee M; Jun BG; Kim TS; Suk KT; Kang SH; Kim MY; Cheon GJ; Kim DJ; Baik SK; Choi DH
J Hepatol; 2018 Nov; 69(5):1066-1073. PubMed ID: 30075230
[TBL] [Abstract][Full Text] [Related]
3. Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B.
Yip TC; Wong GL; Wong VW; Tse YK; Liang LY; Hui VW; Lee HW; Lui GC; Chan HL
J Hepatol; 2020 May; 72(5):847-854. PubMed ID: 31857194
[TBL] [Abstract][Full Text] [Related]
4. PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy.
Papatheodoridis G; Dalekos G; Sypsa V; Yurdaydin C; Buti M; Goulis J; Calleja JL; Chi H; Manolakopoulos S; Mangia G; Gatselis N; Keskin O; Savvidou S; de la Revilla J; Hansen BE; Vlachogiannakos I; Galanis K; Idilman R; Colombo M; Esteban R; Janssen HL; Lampertico P
J Hepatol; 2016 Apr; 64(4):800-6. PubMed ID: 26678008
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B.
Voulgaris T; Papatheodoridi M; Lampertico P; Papatheodoridis GV
Liver Int; 2020 Mar; 40(3):484-495. PubMed ID: 31884726
[TBL] [Abstract][Full Text] [Related]
6. External validation of hepatocellular carcinoma risk scores in patients with chronic hepatitis B virus infection in China.
Lou T; Li B; Xiong P; Jin C; Chen Y
J Viral Hepat; 2021 Oct; 28(10):1373-1380. PubMed ID: 34218498
[TBL] [Abstract][Full Text] [Related]
7. External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals.
Ji JH; Park SY; Son WJ; Shin HJ; Lee H; Lee HW; Lee JS; Kim SU; Park JY; Kim DY; Ahn SH; Kim BK
J Viral Hepat; 2021 Jun; 28(6):951-958. PubMed ID: 33763928
[TBL] [Abstract][Full Text] [Related]
8. Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir.
Kim MN; Hwang SG; Rim KS; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kim SU
Liver Int; 2017 Dec; 37(12):1788-1795. PubMed ID: 28418595
[TBL] [Abstract][Full Text] [Related]
9. PREDICTION OF HEPATOCELLULAR CARCINOMA THROUGH THE MODIFIED PAGE-B SCORE (MPAGE-B) IN PATIENTS WITH CHRONIC HEPATITIS B: IT SHOULD BE USED IN CLINICAL PRACTICE?
Frison PR; Fraga RS
Arq Gastroenterol; 2023; 60(2):172-177. PubMed ID: 37556742
[TBL] [Abstract][Full Text] [Related]
10. Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir.
Chang JW; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Seo YS; Lee HA; Kim MN; Lee YR; Hwang SG; Rim KS; Um SH; Tak WY; Kweon YO; Park SY; Kim SU
J Viral Hepat; 2021 Jan; 28(1):95-104. PubMed ID: 33029863
[TBL] [Abstract][Full Text] [Related]
11. PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.
Chun HS; Papatheodoridis GV; Lee M; Lee HA; Kim YH; Kim SH; Oh YS; Park SJ; Kim J; Lee HA; Kim HY; Kim TH; Yoon EL; Jun DW; Ahn SH; Sypsa V; Yurdaydin C; Lampertico P; Calleja JL; Janssen H; Dalekos GN; Goulis J; Berg T; Buti M; Kim SU; Kim YJ
J Hepatol; 2024 Jan; 80(1):20-30. PubMed ID: 37734683
[TBL] [Abstract][Full Text] [Related]
12. Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir.
Yu JH; Suh YJ; Jin YJ; Heo NY; Jang JW; You CR; An HY; Lee JW
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):865-872. PubMed ID: 30694912
[TBL] [Abstract][Full Text] [Related]
13. Addition of liver stiffness enhances the predictive accuracy of the PAGE-B model for hepatitis B-related hepatocellular carcinoma.
Chon HY; Lee HA; Suh SJ; Lee JI; Kim BS; Kim IH; Lee CH; Jang BK; Lee HW; Hwang JS; Lee CH; Lee JW; Yu JH; Seo YS; Yim HJ; Kim SU;
Aliment Pharmacol Ther; 2021 Apr; 53(8):919-927. PubMed ID: 33465253
[TBL] [Abstract][Full Text] [Related]
14. Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy.
Kim SU; Seo YS; Lee HA; Kim MN; Kim EH; Kim HY; Lee YR; Lee HW; Park JY; Kim DY; Ahn SH; Han KH; Hwang SG; Rim KS; Um SH; Tak WY; Kweon YO; Kim BK; Park SY
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):693-699.e1. PubMed ID: 31252188
[TBL] [Abstract][Full Text] [Related]
15. Validation of the HCC-RESCUE score to predict hepatocellular carcinoma risk in Caucasian chronic hepatitis B patients under entecavir or tenofovir therapy.
Güzelbulut F; Gökçen P; Can G; Adalı G; Değirmenci Saltürk AG; Bahadır Ö; Özdil K; Doğanay HL
J Viral Hepat; 2021 May; 28(5):826-836. PubMed ID: 33586270
[TBL] [Abstract][Full Text] [Related]
16. Comparative Performance of 14 HCC Prediction Models in CHB: A Dynamic Validation at Serial On-Treatment Timepoints.
Wu S; Zhou J; Wu X; Sun Y; Wang B; Kong Y; Zhan S; Jia J; Yang HI; You H
Am J Gastroenterol; 2022 Sep; 117(9):1444-1453. PubMed ID: 35973147
[TBL] [Abstract][Full Text] [Related]
17. Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B.
Papatheodoridis GV; Dalekos GN; Idilman R; Sypsa V; Van Boemmel F; Buti M; Calleja JL; Goulis J; Manolakopoulos S; Loglio A; Papatheodoridi M; Gatselis N; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Yurdaydin C; Esteban R; Janssen HLA; Berg T; Lampertico P
JHEP Rep; 2021 Jun; 3(3):100290. PubMed ID: 34041470
[TBL] [Abstract][Full Text] [Related]
18. An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
Kim HY; Lampertico P; Nam JY; Lee HC; Kim SU; Sinn DH; Seo YS; Lee HA; Park SY; Lim YS; Jang ES; Yoon EL; Kim HS; Kim SE; Ahn SB; Shim JJ; Jeong SW; Jung YJ; Sohn JH; Cho YK; Jun DW; Dalekos GN; Idilman R; Sypsa V; Berg T; Buti M; Calleja JL; Goulis J; Manolakopoulos S; Janssen HLA; Jang MJ; Lee YB; Kim YJ; Yoon JH; Papatheodoridis GV; Lee JH
J Hepatol; 2022 Feb; 76(2):311-318. PubMed ID: 34606915
[TBL] [Abstract][Full Text] [Related]
19. Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy.
Nam JY; Sinn DH; Bae J; Jang ES; Kim JW; Jeong SH
JHEP Rep; 2020 Dec; 2(6):100175. PubMed ID: 33117971
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.
Papatheodoridis GV; Sypsa V; Dalekos GN; Yurdaydin C; Van Boemmel F; Buti M; Calleja JL; Chi H; Goulis J; Manolakopoulos S; Loglio A; Voulgaris T; Gatselis N; Keskin O; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Idilman R; Esteban R; Janssen HLA; Berg T; Lampertico P
J Hepatol; 2020 Jun; 72(6):1088-1096. PubMed ID: 31981727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]